CRSP CRISPR Therapeutics

Watchlist

Close Apr 26 16:00 ET

Post 19:59 ET

4.58BMarket Cap-27788P/E (TTM)

CRISPR Therapeutics Stock Analyst Ratings & Price Target

Updated: Apr 28, 2024

Based on 16 analysts giving stock ratings to CRISPR Therapeutics in the past 3 months

Buy

Updated: Apr 28, 2024

The average CRISPR Therapeutics stock price target is 81.00 with a max estimate of 112.00 and a min estimate of 30.00

Review CRISPR Therapeutics earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 28, 2024

Buy

Updated: Apr 28, 2024

Overall